NorthWest Biotherapeutics Inc (NWBO)

[Pungstaur]

The scientist & the lawyer...

Having listened to LL speak yesterday and followed this board for a bit, I feel it’s obvious that both LL & LP want this long clinical trial to succeed.

LL seemed to politely state her dismay with the lengthy FDA regulatory process for approval of trials, at the expense of patients. And the mechanism for trials.

LP must have great interest in the success of the trial for the company’s well being ( 100,000,000 shares).

With the vast amount of data, it seems reasonable that there could be some differences of opinions among the involved parties, as goes for which endpoint to apply certain data sets, triggering requests for review and justification for which endpoint data is applied to.

If that’s the case, there could possibly be a lot of back and forth between the statisticians, the scientists and the lawyers, and possibly that is what’s driving us nuts waiting for PR.

If any of this has taken place, it most certainly would not have helped the SP if they PR’ed uncertainties to the public.